Best Practice for Sex Inclusive Research

Dr Natasha Karp, Director of Statistics, AstraZeneca, United Kingdom
Professor Amrita Ahluwalia, Director of the Barts Cardiovascular CTU, Queen Mary University of London, United Kingdom

A workshop looking to assess a training intervention for sex inclusive research for the British Pharmacology Society (BPS). During the training we will be looking to explore both the misconceptions and practical blockers to sex inclusive research. We will explore what sex and gender inclusive research is and when sex and gender should be considered. We will discuss the drivers behind the changing landscape on sex inclusive research. We will then consider the blockers to sex inclusive research and finally we will explore how to analyse and power experiments with both sexes. This will be an interactive workshop with the ‘hosts speaking briefly and the rest of the time allocation devoted to an interactive session led by Dr Phillips and Gaskill for the poll and consideration and work through by attendees of an example study design. This will include an interactive section where in small groups the scientists apply the knowledge gained in scenario exploration where a design question is posed and the scientists suggest the solution.

Scene setting and exploration of current state of play of attending audience-series of poll
Professor Amrita Ahluwalia
Director of the Barts Cardiovascular CTU, Queen Mary University of London, United Kingdom

Understanding the changing landscape of sex inclusive research
Dr Natasha Karp
Director of Statistics, AstraZeneca, United Kingdom

Including both sexes in in vivo research does not necessitate an increase in sample size: a key role for factorial analysis methods
Dr Benjamin Phillips
Senior Statistician, AstraZeneca, United Kingdom

Scenario exploration and debate and exit poll
Dr Brianna Gaskill
3R Scientist, Novartis, United States of America